Dawes Fretzin Clinical Research Group

Indianapolis, Indiana 46260

0 studies enrolling now · 26 studies all time

What they study most

Acne, Acne Inversa, Acne Vulgaris, Actinic Keratosis, Atopic Dermatitis, Atopic Dermatitis Eczema, Chronic Hand Dermatitis, Common Warts, Cutaneous Neurofibroma, Dermatitis, Atopic, Eczema, HPV (Human Papillomavirus)

Studies at this site

• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis — Completed
• Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne — Running, not enrolling
• Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects — Running, not enrolling
• NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) — Completed
• LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) — Completed
• LEO 90100 in the Treatment of Psoriasis Vulgaris — Completed
• LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris — Completed
• Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis — Completed
• A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis — Completed
• Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis — Completed
• A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa — Stopped early
• Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
• A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa — Completed
• Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) — Completed
• A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis — Stopped early
• Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema — Completed
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) — Completed
• Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis — Completed
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed
• Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) — Status unconfirmed
• Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne — Completed
• Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
• A Twelve Week Safety and Efficacy Study in Rosacea — Completed
• Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy — Completed